Skip to content
The third NMIC bulletin of 2024 focuses on the ‘Use of medicines with anticholinergic activity’
NMIC Therapeutics Today (May-Number 5): In addition to its regular features, this month’s edition focuses on:
- Risk of adverse events following initiation of antihypertensives in people with complex health needs
- Age-related risk of serious fall events and opioid analgesic use
- Use of progestogens and the risk of intracranial meningioma
- Recent NMIC Bulletins on Breast cancer and Prostate cancer
- Guidance, advice and suggested reading documents
- NMIC CPD module
Previous editions of the Therapeutics Today newsletters, and NMIC therapeutic bulletins are also available on the NMIC website.
